Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
1.220
+0.010 (0.83%)
Nov 7, 2024, 4:00 PM EST - Market closed
Apyx Medical Revenue
Apyx Medical had revenue of $12.15M in the quarter ending June 30, 2024, a decrease of -10.47%. This brings the company's revenue in the last twelve months to $49.03M, up 3.36% year-over-year. In the year 2023, Apyx Medical had annual revenue of $52.35M with 17.61% growth.
Revenue (ttm)
$49.03M
Revenue Growth
+3.36%
P/S Ratio
0.85
Revenue / Employee
$194,567
Employees
252
Market Cap
42.27M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 52.35M | 7.84M | 17.61% |
| Dec 31, 2022 | 44.51M | -4.01M | -8.26% |
| Dec 31, 2021 | 48.52M | 20.81M | 75.08% |
| Dec 31, 2020 | 27.71M | -524.00K | -1.86% |
| Dec 31, 2019 | 28.24M | 11.63M | 70.04% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CareCloud | 111.75M |
| LakeShore Biopharma | 79.42M |
| DURECT | 8.41M |
| vTv Therapeutics | 1.00M |
| CollPlant Biotechnologies | 689.00K |
| Lexaria Bioscience | 411.02K |
| Incannex Healthcare | 12.00K |
APYX News
- 13 days ago - Apyx Medical Corporation to Release Third Quarter Of Fiscal Year 2024 Financial Results on November 8, 2024 - GlobeNewsWire
- 3 months ago - Renuvion Named #1 Trusted Body Contouring Technology by Doctors* - PRNewsWire
- 3 months ago - Apyx Medical Corporation (APYX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Comparing the Use of Renuvion to a Competing Technology Following Liposuction or Body Contouring Procedures - Business Wire
- 3 months ago - Apyx Medical Corporation Reports Second Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook - Business Wire
- 3 months ago - Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024 - Business Wire
- 4 months ago - Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health - PRNewsWire
- 6 months ago - Apyx Medical Corporation (APYX) Q1 2024 Earnings Call Transcript - Seeking Alpha